B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature-Reference-Cited by-同舟云学术

B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature

Published:2023-07-17 Issue:10 Volume:64 Page:1701-1705
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Arribas I.¹,Maluquer C.¹,Pomares H.¹,Carro I.¹,Baca C.¹,Bosch A.¹,Arévalo C. E.¹,Montané C.¹,Ribes-Amorós J.¹,Zamora L.²,Granada I.²,Gamundi E.³,Arnan M.¹,Sureda A.¹

Affiliation:

1. Clinical Hematology Department IDIBELL, Catalan Institute of Oncology, Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain

2. Hematology Department, ICO-Hospital Germans Trias i Pujol, José Carreras Leukemia Research Institute, Badalona, Spain

3. Pathology Department, Bellvitge University Hospital, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2234527

Reference25 articles.

1. Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project

2. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

3. Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma

4. Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

5. Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lenalidomide;Reactions Weekly;2024-01-13